News
05-31-2014, 06:10 AM
Boehringer Ingelheim today announced that new data will be presented from 7 abstracts for Gilotrif (afatinib) and investigational compounds, including nintedanib and BI 836845, from its oncology pipeline at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, on May 30 – June 3, 2014.
More... (http://www.news-medical.net/news/20140531/New-data-on-Gilotrif-and-investigational-compounds-to-be-presented-at-50th-ASCO-annual-meeting.aspx)
More... (http://www.news-medical.net/news/20140531/New-data-on-Gilotrif-and-investigational-compounds-to-be-presented-at-50th-ASCO-annual-meeting.aspx)